Cemsidomide (CFT7455)
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
Arms / Cohorts
Phase 1, Arm A:Cemsidomide: R/R Non-Hodgkins Lymphoma or R/R Multiple Myeloma
Accepting patients
Phase 1, Arm B1:Cemsidomide: R/R Multiple Myeloma
Accepting patients
Phase 1, Arm B2:Cemsidomide + Dexamethasone: R/R Multiple Myeloma
Accepting patients
Experimental - Phase 1, Arm C:Cemsidomide: R/R Non-Hodgkins Lymphoma
Accepting patients
Phase 2, Arm 1:Cemsidomide: R/R Multiple Myeloma
Not yet accepting
Phase 2, Arm 2:Cemsidomide + Dexamethasone: R/R Multiple Myeloma
Not yet accepting
Experimental: Phase 2, Arm 3:Cemsidomide: R/R Mantle Cell Lymphoma
Not yet accepting
Experimental: Phase 2, Arm 4:Cemsidomide: R/R Peripheral T-Cell Lymphoma
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.